Anergis Receives Swiss Life Sciences Prize

(PresseBox) ( Epalinges, Switzerland, )
.
- Prestigious annual award under the patronage of the Swiss Biotech Association and BioValley Basel
- Sponsored by BB Biotech Ventures, Novartis Venture Fund and Venture Incubator

Anergis, a company focusing on proprietary allergy vaccines, today announced it has been awarded the Swiss Life Sciences Prize 2013. The prize, which has been granted for the tenth time in 2013, is under the patronage of the Swiss Biotech Association and BioValley Basel. Sponsors of the Swiss Life Sciences Prize are BB Biotech Ventures, Novartis Venture Fund and Venture Incubator. Jury members are Dr. Philippe Dro (CEO, GlycoVaxyn AG), Dr. Reinhard Glück (Former President, Swiss Biotech Association), Dr. Franz Saladin (Director, Chamber of Commerce of Basel), Dr. Dieter Scholer (Member, University Council, University of Basel), Dr. Matthias Staehelin (Head Life Sciences, VISCHER) and Jürg Zürcher (EMEIA Biotechnology Leader, Ernst & Young).

"We are delighted that Anergis has been chosen as the winner of this year's Swiss Life Sciences Award," said Vincent Charlon, CEO of Anergis. "The award underlines Anergis' achievements and the value of its COP allergy vaccine pipeline. It also reflects the fact that Anergis is a leading actor of the Swiss biotechnology industry. Just recently, we have successfully completed a Phase IIb trial with our lead compound AllerT, a birch pollen allergy vaccine. We are looking forward to initiating Phase III clinical trials next year."

Philippe Dro, CEO of GlycoVaxyn and member of the jury, stated: "We are impressed how the Anergis team made progress in an area often neglected by the industry and is on its way to making a significant contribution to the field of vaccines. With the combination of a technology, a motivated team and financing from Swiss sources, Anergis presents a great showcase for practical possibilities for start-ups in Switzerland."
Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an service@pressebox.de.